Oláh E, Rák K
Int J Cancer. 1981 Mar 15;27(3):287-95. doi: 10.1002/ijc.2910270306.
Twenty-three patients in various cytological subgroups of blast phase of Ph1-positive chronic myeloid leukaemia were investigated cytogenetically The correlation between prognosis and the cytological and cytogenetic features of blast cells was studied. The best prognosis was found in the myeloid group, followed by the lymphoid, myelomonocytic, megakaryoblastic and finally the promyelocytic groups, in this order. As regards the prognostic significance of the cytogenetic finding, the survival seemed to be the longest among patients with mosaic karyotypes i.e. when further aberrations occurred in some Ph1-positive cells. The course of the disease was the most favourable in the presence of i(17q), especially in patients whose cells had i(17q) as the only aberration. The most severe course of the disease could be found in patients with +8 and/or two Ph1. The results demonstrate the usefulness of chromosome investigations in distinguishing the different cytogenetic subgroups in terminal stages of CML, which also differ prognostically from each other.
对23例Ph1阳性慢性髓性白血病急变期不同细胞学亚组的患者进行了细胞遗传学研究。研究了急变期细胞的预后与细胞学和细胞遗传学特征之间的相关性。预后最好的是髓细胞组,其次是淋巴细胞组、粒单核细胞组、巨核细胞组,最后是早幼粒细胞组,顺序依次如此。至于细胞遗传学发现的预后意义,嵌合核型的患者生存时间似乎最长,即当一些Ph1阳性细胞出现进一步畸变时。疾病进程在存在i(17q)时最为有利,尤其是那些细胞仅有i(17q)这一畸变的患者。疾病进程最严重的见于有+8和/或两个Ph1的患者。结果表明染色体检查对于区分慢性髓性白血病终末期不同的细胞遗传学亚组有用,这些亚组在预后方面也彼此不同。